Orphan Drugs & Rare Diseases Global Congress 2016 Americas will provide a unique platform for the convergence of stakeholders in the orphan drugs industry to discuss and network with top tier government, hospitals, pharmaceuticals, biopharmaceuticals, nonprofit organizations, orphan drugs developers as well as regional and local manufacturers. We are putting together an agenda that address the driving macroeconomic factors, policies and issues that will steer the development of orphan drugs globally including commercialization, policies, reimbursement, pricing and more.
Dr. Tim Cote has been honored with a speaking slot at this conference and will be presenting at 12:00pm on the 29th. He will follow this with a session on the Market Access for Orphan Drugs: Looking Into the Future Panel.
Brian Dwyer, our Vice President of Business Development, will also be a panelist on the Advancing Orphan Drug Innovation and Access in Emerging Markets panel.